These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22796330)

  • 1. The contribution of age structure to cell population responses to targeted therapeutics.
    Gabriel P; Garbett SP; Quaranta V; Tyson DR; Webb GF
    J Theor Biol; 2012 Oct; 311():19-27. PubMed ID: 22796330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stilbene Compounds Inhibit Tumor Growth by the Induction of Cellular Senescence and the Inhibition of Telomerase Activity.
    Lee YH; Chen YY; Yeh YL; Wang YJ; Chen RJ
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159515
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer cell senescence: a new frontier in drug development.
    Cairney CJ; Bilsland AE; Evans TR; Roffey J; Bennett DC; Narita M; Torrance CJ; Keith WN
    Drug Discov Today; 2012 Mar; 17(5-6):269-76. PubMed ID: 22314100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor senescence as a determinant of drug response in vivo.
    Roninson IB
    Drug Resist Updat; 2002 Oct; 5(5):204-8. PubMed ID: 12450785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Cancer Metabolism and Cell Cycle by Plant-Derived Compounds.
    Çoban EA; Tecimel D; Şahin F; Deniz AAH
    Adv Exp Med Biol; 2020; 1247():125-134. PubMed ID: 31749136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of senescence in cancer cells by 5'-Aza-2'-deoxycytidine: Bioinformatics and experimental insights to its targets.
    Putri JF; Widodo N; Sakamoto K; Kaul SC; Wadhwa R
    Comput Biol Chem; 2017 Oct; 70():49-55. PubMed ID: 28802167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of cellular senescence in cancer therapy: is it true or not?
    Zhang Y; Yang JM
    Acta Pharmacol Sin; 2011 Oct; 32(10):1199-207. PubMed ID: 21909124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasis.
    McCubrey JA; Lertpiriyapong K; Fitzgerald TL; Martelli AM; Cocco L; Rakus D; Gizak A; Libra M; Cervello M; Montalto G; Yang LV; Abrams SL; Steelman LS
    Adv Biol Regul; 2017 Jan; 63():32-48. PubMed ID: 27776972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4,5-Diphenyl-2-methyl picolinate induces cellular senescence by accumulating DNA damage and activating associated signaling pathways in gastric cancer.
    Zhao Z; Shang D; Qiu L; Guo C; Li Y; Liu H; Yuan G; Tu Z
    Life Sci; 2019 Dec; 238():116973. PubMed ID: 31639393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle specificity of anticancer agents.
    van Putten LM
    Antibiot Chemother (1971); 1978; 23():128-34. PubMed ID: 348073
    [No Abstract]   [Full Text] [Related]  

  • 11. Mathematical analysis of cancer chemotherapy: the effects of chemotherapeutic agents on the cell cycle traverse.
    Chuang SN; Soong TT
    Bull Math Biol; 1978; 40(4):499-512. PubMed ID: 678695
    [No Abstract]   [Full Text] [Related]  

  • 12. Cellular Senescence-Inducing Small Molecules for Cancer Treatment.
    Liu P; Lu Z; Wu Y; Shang D; Zhao Z; Shen Y; Zhang Y; Zhu F; Liu H; Tu Z
    Curr Cancer Drug Targets; 2019; 19(2):109-119. PubMed ID: 29848278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BH3 mimetic ABT-737 induces cancer cell senescence.
    Song JH; Kandasamy K; Zemskova M; Lin YW; Kraft AS
    Cancer Res; 2011 Jan; 71(2):506-15. PubMed ID: 21084274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cellular synchronization and "recruitment" in antineoplastic chemotherapy].
    Lingetti M; Belli M; Guerriero C; Rumiano C; Ciarimboli M; Policicchio D
    Clin Ter; 1980 Apr; 93(2):203-11. PubMed ID: 7449338
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer therapy: targeting cell cycle regulators.
    Johansson M; Persson JL
    Anticancer Agents Med Chem; 2008 Oct; 8(7):723-31. PubMed ID: 18855574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Kinase Modulators in Cellular Senescence for Use in Cancer Treatment.
    Lee CS; Baek J; Han SY
    Molecules; 2017 Aug; 22(9):. PubMed ID: 28841181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review: potential role of cell cycle synchronizing agents in combination treatment modalities of malignant tumors.
    Zalatnai A
    In Vivo; 2005; 19(1):85-91. PubMed ID: 15796159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity.
    Malaquin N; Vancayseele A; Gilbert S; Antenor-Habazac L; Olivier MA; Ait Ali Brahem Z; Saad F; Delouya G; Rodier F
    Cells; 2020 Jul; 9(7):. PubMed ID: 32630281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular Senescence and Anti-Cancer Therapy.
    You J; Dong R; Ying M; He Q; Cao J; Yang B
    Curr Drug Targets; 2019; 20(7):705-715. PubMed ID: 30556499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Resveratrol on Cellular Senescence in Normal and Cancer Cells: Focusing on Cancer and Age-Related Diseases.
    Farhadnejad H; Emamat H; Zand H
    Nutr Cancer; 2019; 71(7):1175-1180. PubMed ID: 30955382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.